Abstract
Patients with cancer are at high risk to develop venous thromboembolism as well as arterial thrombosis. Well established treatment patterns of these vascular complications are often hampered in cancer patients by disturbances of coagulation or thrombocytopenia. Therefore standardized interventions or medical treatment can be difficult to perform. As data from clinical trials or recommendations from guidelines are sparse, complicated cases have to be dealt with an interdisciplinary single patient approach. Thus in patients with STEMI application of a drug eluting stent which might be the best treatment in a non-cancer patient may not be feasible. In cancer patients with venous thromboembolism and bleeding the implantation of a vena cava filter might be necessary.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
